347 related articles for article (PubMed ID: 21226933)
1. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.
Lu B; Kumar A; Castellsagué X; Giuliano AR
BMC Infect Dis; 2011 Jan; 11():13. PubMed ID: 21226933
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.
Rambout L; Hopkins L; Hutton B; Fergusson D
CMAJ; 2007 Aug; 177(5):469-79. PubMed ID: 17671238
[TBL] [Abstract][Full Text] [Related]
4. HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis.
La Torre G; de Waure C; Chiaradia G; Mannocci A; Ricciardi W
Vaccine; 2007 Dec; 25(50):8352-8. PubMed ID: 17996990
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
Arbyn M; Xu L
Expert Rev Vaccines; 2018 Dec; 17(12):1085-1091. PubMed ID: 30495978
[TBL] [Abstract][Full Text] [Related]
6. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.
; Romanowski B; de Borba PC; Naud PS; Roteli-Martins CM; De Carvalho NS; Teixeira JC; Aoki F; Ramjattan B; Shier RM; Somani R; Barbier S; Blatter MM; Chambers C; Ferris D; Gall SA; Guerra FA; Harper DM; Hedrick JA; Henry DC; Korn AP; Kroll R; Moscicki AB; Rosenfeld WD; Sullivan BJ; Thoming CS; Tyring SK; Wheeler CM; Dubin G; Schuind A; Zahaf T; Greenacre M; Sgriobhadair A
Lancet; 2009 Dec; 374(9706):1975-85. PubMed ID: 19962185
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials of human papillomavirus vaccines and beyond.
Lehtinen M; Dillner J
Nat Rev Clin Oncol; 2013 Jul; 10(7):400-10. PubMed ID: 23736648
[TBL] [Abstract][Full Text] [Related]
8. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis.
Lin R; Jin H; Fu X
Expert Rev Vaccines; 2023; 22(1):1168-1178. PubMed ID: 37990881
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of commercially available vaccines against HPV infection in women: a systematic review and meta-analysis].
Araujo SC; Caetano R; Braga JU; Costa e Silva FV
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S32-44. PubMed ID: 25402248
[TBL] [Abstract][Full Text] [Related]
11. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
Naud PS; Roteli-Martins CM; De Carvalho NS; Teixeira JC; de Borba PC; Sanchez N; Zahaf T; Catteau G; Geeraerts B; Descamps D
Hum Vaccin Immunother; 2014; 10(8):2147-62. PubMed ID: 25424918
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of human papillomavirus vaccines: a systematic quantitative review.
Medeiros LR; Rosa DD; da Rosa MI; Bozzetti MC; Zanini RR
Int J Gynecol Cancer; 2009 Oct; 19(7):1166-76. PubMed ID: 19823051
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
McIntosh J; Sturpe DA; Khanna N
J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
[TBL] [Abstract][Full Text] [Related]
14. HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis.
Mac Eochagain C; Power R; Parker I; Brennan D
J Gynecol Oncol; 2022 May; 33(3):e24. PubMed ID: 35128855
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
[TBL] [Abstract][Full Text] [Related]
17. Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up study.
Zhao F; Jastorff A; Hong Y; Hu S; Chen W; Xu X; Zhu Y; Zhu J; Zhang X; Zhang W; Xu D; Wang D; Tang R; Sun Y; Shen Y; Pan Q; Yin J; Liu D; Liu B; Karkada N; Jiang C; Cui J; Chen F; Bi J; Bao Y; Zhou X; Cartier C; Hu Y; Borys D
Asia Pac J Clin Oncol; 2023 Aug; 19(4):458-467. PubMed ID: 36101936
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge.
Wang R; Pan W; Jin L; Huang W; Li Y; Wu D; Gao C; Ma D; Liao S
Cancer Lett; 2020 Feb; 471():88-102. PubMed ID: 31812696
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus disease and vaccines.
Hutchinson DJ; Klein KC
Am J Health Syst Pharm; 2008 Nov; 65(22):2105-12. PubMed ID: 18997137
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC; Teixeira JC; Jaisamrarn U; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Mindel A; de Sutter P; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G;
Clin Vaccine Immunol; 2015 Apr; 22(4):361-73. PubMed ID: 25651922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
